IKT
Inhibikase Therapeutics, Inc.
There isn't enough reported data to score IKT yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
IKT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
IKT's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
IKT PE Valuation
IKT has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
IKT Forward outlook
There aren't enough analyst estimates for IKT to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
IKT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$2.68 | +$1.33 |
| Q2 2024 | -$2.89 | +$1.34 |
| Q1 2024 | -$3.34 | +$0.86 |
| Q4 2023 | -$3.57 | +$0.75 |
| Q3 2023 | -$4.01 | +$0.13 |
| Q2 2023 | -$4.23 | -$0.09 |
| Q1 2023 | -$4.20 | +$0.18 |
| Q4 2022 | -$4.32 | +$0.54 |
UNH has the stronger earnings trend. Trailing diluted EPS is down 115% for IKT versus UNH down 8.5%.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
IKT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $1 | -100% |
| Q3 2023 | $79.6K | +991% |
| Q2 2023 | $116.4K | +1677% |
| Q1 2023 | $64.5K | +40% |
| Q4 2022 | $63.6K | +3170% |
| Q3 2022 | $7.3K | -98% |
| Q2 2022 | $6.6K | -100% |
| Q1 2022 | $46K | -97% |
IKT's revenue is shrinking: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2023 | -440356600% | -440349780 points |
| Q3 2023 | -5993% | +55906 points |
| Q2 2023 | -5328% | +65489 points |
| Q1 2023 | -7308% | +2774 points |
| Q4 2022 | -6820% | +252515 points |
| Q3 2022 | -61900% | -60538 points |
| Q2 2022 | -70817% | -70624 points |
| Q1 2022 | -10081% | -9895 points |
IKT's operating margin was −440356600% last quarter, down 440349780 points from the same quarter a year ago, near the bottom of its range since 2019.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
IKT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$17.4M | -$6.8M |
| Q2 2026 | -$12.4M | -$6.9M |
| Q1 2026 | -$12.1M | -$7.9M |
| Q4 2025 | -$7.5M | -$2.2M |
| Q3 2025 | -$10.6M | -$5.7M |
| Q1 2025 | -$4.1M | -$249.9K |
| Q4 2024 | -$5.3M | -$1.9M |
| Q3 2024 | -$4.9M | -$776K |
IKT has burned cash in almost every quarter: −$49M over the past year, against −$26M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over IKT on cash generation, producing positive trailing cash flow while its opponent burns cash.
IKT Net Leverage
IKT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
IKT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.4 | Neutral |
| Stochastic | 6.5 | Oversold |
IKT's weekly RSI is 35 (neutral) and its Stochastic is 6 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
IKT PE vs Healthcare Sector
IKT has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
IKT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.73 | 12% below |
| 20 week MA | $2.07 | 26% below |
| 50 week MA | $1.89 | 19% below |
| 100 week MA | $1.95 | 22% below |
| 200 week MA | $2.13 | 28% below |
IKT is in a downtrend: it's below all five of its weekly moving averages, and 28% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over IKT on trend strength, trading above more of its moving averages.
IKT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $58.8 | $58.8 | 0% |
| 2021 | $58.8 | $9.42 | -84% |
| 2022 | $9.42 | $2.97 | -68% |
| 2023 | $2.97 | $1.27 | -57% |
| 2024 | $1.27 | $3.05 | +140% |
| 2025 | $3.05 | $2.00 | -34% |
| 2026 YTD | $2.00 | $1.53 | -24% |
IKT's yearly returns have swung widely, from +140% in 2024 to −84% in 2021. It's down 24% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over IKT on returns for 2026, with the stronger performance.